Drupal.behaviors.print = function(context) {window.print();window.close();}>

Takeda to Use Zinfandel TOMM40 Biomarker Assay for Alzheimer's Drug Study

January 11, 2011

Takeda to Use Zinfandel TOMM40 Biomarker Assay for Alzheimer's Drug Study

Takeda has taken an exclusive, worldwide license for the use of Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories